Also trades as: EVGN.TA (TLV) · $vol 0M
EVGN NASDAQ
Evogene Ltd.
1W: +2.2%
1M: -21.2%
3M: -3.0%
YTD: -62.4%
1Y: -63.0%
3Y: -92.9%
5Y: -98.5%
$0.42
-0.01 (-2.43%)
Weekly Expected Move ±12.3%
$0
$0
$0
$0
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$4M
-54.7% ▼
5Y CAGR: +29.9%
Gross Profit
$795K
-76.5% ▼
Operating Income
-$14M
+35.6% ▲
Net Income
-$8M
+48.5% ▲
EPS (Diluted)
$-1.08
+62.6% ▲
EBITDA
-$13M
+16.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $930K | $2M | $6M | $9M | $4M |
| YoY Growth | -10.6% | +80.1% | +236.7% | +50.9% | -54.7% |
| Cost of Revenue | $3M | $3M | $4M | $5M | $3M |
| Gross Profit | -$2M | -$2M | $1M | $3M | $795K |
| Gross Margin | -222.7% | -105.9% | 24.8% | 39.8% | 20.6% |
| R&D Expenses | $19M | $18M | $18M | $14M | $8M |
| SG&A Expenses | $10M | $10M | $10M | $11M | $5M |
| Operating Expenses | $29M | $28M | $28M | $25M | $15M |
| Operating Income | -$31M | -$30M | -$26M | -$22M | -$14M |
| Operating Margin | -3386.0% | -1774.0% | -467.9% | -255.4% | -363.3% |
| Interest Expense | $403K | $241K | $171K | $124K | $2M |
| Income Before Tax | -$30M | -$30M | -$26M | -$18M | -$13M |
| Tax Expense | $13K | $90K | -$33K | $9K | -$1K |
| Net Income | -$28M | -$27M | -$24M | -$16M | -$8M |
| Net Margin | -2988.5% | -1590.3% | -423.4% | -193.7% | -220.2% |
| EPS (Diluted) | $-0.68 | $-6.46 | $-5.23 | $-2.89 | $-1.08 |
| EBITDA | -$28M | -$27M | -$23M | -$15M | -$13M |
| Shares Outstanding | 41M | 4M | 5M | 6M | 8M |